Call Options Transactions Made in Q3 2024 in Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS) during Q3 2024. The information is specifically focused on institutions that hold call options of Tarsus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
300KNew |
$6.46M - $10.4M
|
300K
$15.9M
|
|
|
Nov 14, 2024
Q3 2024
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
94.5KNew |
$2.04M - $3.27M
|
94.5K
$5M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
41.7KNew |
$898K - $1.44M
|
41.7K
$2.21M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
7.9K+ 114.49% |
$170K - $273K
|
14.8K
$783K
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
CALL |
5KNew |
$108K - $173K
|
5K
$265K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-3.4K- 10.97% |
$73.2K - $118K
|
27.6K
$1.46M
|